NNNN

Anbio Biotechnology
NNNN

10 hedge funds and large institutions have $2.54M invested in Anbio Biotechnology in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$389K
2
+$322K
3
+$306K
4
Millennium Management
Millennium Management
New York
+$264K
5
XT
XTX Topco
Cayman Islands
+$257K

Top Sellers

1
-$363K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$960K
Marshall Wace
2
Marshall Wace
United Kingdom
$389K
Morgan Stanley
3
Morgan Stanley
New York
$321K
Millennium Management
4
Millennium Management
New York
$264K
XT
5
XTX Topco
Cayman Islands
$257K
HF
6
HRT Financial
New York
$223K
BNP Paribas Financial Markets
7
BNP Paribas Financial Markets
France
$90.1K
UBS Group
8
UBS Group
Switzerland
$35.8K
Wells Fargo
9
Wells Fargo
California
$3.73K
Bank of America
10
Bank of America
North Carolina
$782